CS logo
small CS logo
Nakamura Cardiovascular Clinic

Itoshima, Fukuoka, Japan
糸島市の心臓専門医

About Nakamura Cardiovascular Clinic


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Eli Lilly and Company
1
Total Rows: 2

Clinical Trials at Nakamura Cardiovascular Clinic


During the past decade, Nakamura Cardiovascular Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100111100001100Started TrialsCompleted Trails202020212022202300.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.
2020-01-30
2021-10-08
Completed
755
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
2023-02-03
2025-01-08
Recruiting
432

Rows per page:

1–3 of 3

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsBayer: 2Bayer: 2Eli Lilly and Company: 1Eli Lilly and Company: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Nakamura Cardiovascular Clinic


According to Clinical.Site data, the most researched conditions in "Nakamura Cardiovascular Clinic" are "Atrial Fibrillation" (1 trials), "Atrial Fibrillation (AF)" (1 trials), "Heart Failure" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Nakamura Cardiovascular Clinic" in a lesser frequency.

Clinical Trials Intervention Types at Nakamura Cardiovascular Clinic


Most popular intervention types in "Nakamura Cardiovascular Clinic" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Nakamura Cardiovascular Clinic


The vast majority of trials in "Nakamura Cardiovascular Clinic" are 3 trials for "All" genders.

Clinical Trials Status at Nakamura Cardiovascular Clinic


Currently, there are NaN active trials in "Nakamura Cardiovascular Clinic". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nakamura Cardiovascular Clinic, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nakamura Cardiovascular Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 2Recruiting: 2Completed: 1Completed: 1